Underweight EMR: Calibrated 40% trim in two tranches with ATR-based stops, residual preserved for Q4 FY26 catalyst
The neutral analyst's calibrated framework is adopted: 40% reduction in two tranches with 2x ATR stops aligned to technical structure, correcting the trader's $163 stop error. Preserve 55-60% residual for Q4 optionality. Dense bearish convergence (MACD bearish crossover, price below VWAP/VWAP, RSI cooling from 72 to 55, failed Bollinger Band breakout, forward P/E 21.4x requiring 41% EPS step-up) supports Underweight direction. The 8/26 reflection's alpha-cost ceiling (-3.5% cumulative from three consecutive Holds) supersedes the trim-tax lesson from 8/20/8/21. Full Sell is avoided per 8/20 (+1.2% opportunity cost) and 8/25 (-2.1% direct alpha loss) reflection record. The Q4 FY26 print is the validating catalyst: if it delivers beat-and-raise with FY27 guide above $6.55, dense bearish thesis is invalidated and re-engagement is triggered above $164.30.
| Position | Action |
|---|---|
| Tranche 1 entry zone $158-160 | Sell 20% of position |
| Tranche 2 entry zone $162-163 | Sell 20% of position |
| Preserve residual for Q4 FY26 print | Hold 55-60% residual position |
EMR's technical consolidation is a healthy bull-flag within an accelerating fundamental story — sequential EPS inflection, structural margin expansion, $3.7B FCF generation, and multi-decade Equinor contract visibility create a base for the next leg higher, not a top.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 55.32 | neutral |
| MACD Line | 2.61 | bullish |
| MACD Signal Line | 3.56 | bullish |
| MACD Histogram | −0.95 | bearish |
| 20-Day SMA (Bollinger Middle) | 158.40 | neutral |
| Bollinger Upper Band (2σ) | 165.82 | neutral |
| Bollinger Lower Band (2σ) | 150.98 | neutral |
| 50-Day SMA | 148.48 | bullish |
| 200-Day SMA | 141.05 | bullish |
| 10-Day EMA | 157.63 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $162-163 zone
Then: Reduce 20% of position
Sequential EPS is inflecting sharply — Q3 shows 23% sequential jump, forward consensus implies ~58% growth
↩ rebuts: “Bear's 'priced in' thesis — forward P/E of 21.4x with PEG of 1.79 is not priced for perfection”
EV: +15% (to $181 at 25x forward P/E vs. current $157) · concedes: Technical analyst's call for patience on a fresh entry trigger is tactically reasonable; A break above 163 with volume would be a cleaner breakout entry; A flush to 150.98 would be a cleaner buy point to reset RSI; Position sizing should account for 12-24 month thesis timeframe; Hard stop below 200 SMA at $141 for risk management
EMR's consolidation pattern is a distribution top, not a launchpad—failed technical breakout at upper Bollinger Band, valuation requiring 41% EPS acceleration on a 34x stock with $18.2B goodwill, negative tangible book, and no retail bid cushion.
EV: -9% to -22% · concedes: Frame agreements and long-cycle contracts provide SOME revenue visibility, even if slow-burn; FCF generation is real at $3.7B TTM; capital return program is technically self-funded; NI/AspenTech acquisitions did provide higher-margin software mix; Data-center power-generation capex is a marginal tailwind, however small; 89% no-cuts probability does reduce near-term recession risk
→ vs conservative: Conservative analyst's 'premium valuation reflecting confidence' framing masks a value trap — at 34.5x P/E pricing in 41% EPS growth, there is no margin of safety if integration risks from AspenTech or National Instruments acquisitions surface
→ vs conservative: Negative tangible book value of -$7.4B with goodwill at 31% of market cap is not a footnote — it is an impairment trigger waiting to happen if NI franchise stumbles
→ vs neutral: Neutral analyst's 'trend is your friend' HOLD argument ignores that MACD histogram flipped negative at -0.95 and VWMA at 159.41 acted as resistance twice — the chart is at an inflection point, not a confirmed uptrend
→ vs neutral: Waiting for 'confirmation' on the breakout means buying back higher or selling lower — the flag is losing upward bias as evidenced by price hugging flat 10 EMA while MACD turns negative
| 20-Day VWMA | 159.41 | bearish |
| ATR (14) | 3.93 | neutral |
| Golden Cross | 50 SMA (148.48) > 200 SMA (141.05) | bullish |
Support: 154.72 · 150.98 · 148.48 · 141.05 | Resistance: 158.4 · 163 · 165.82
EMR exhibits a mature bullish cycle with the stock up sharply from July 2026 lows, now digesting gains near multi-month highs. The MACD histogram has flipped negative (−0.95) with price stalling around the 10 EMA, while a neutral RSI (55.32) confirms consolidation is neither overbought nor oversold. The stock is rated HOLD as the near-term bias is neutral/soft pending directional resolution between 163 (breakout) and 150.98 (breakdown), though longer-term structure remains bullishly biased with Golden Cross configuration intact.
Market Cap
$86.56 B
Share Price (52-Week)
$122.64 – $166.35
50-Day MA
$148.88
200-Day MA
$142.05
P/E (TTM)
33.96
Forward P/E
21.42
PEG Ratio
1.79
Price / Book
4.25
Beta
1.235
Dividend Yield
1.41%
EPS (TTM)
$4.57
Forward EPS
$7.24
Book Value
$36.54
FY2025 Revenue
$18,016 M
FY2025 Gross Profit
$9,519 M
FY2025 Gross Margin
52.8%
FY2025 Operating Income
$3,532 M
FY2025 Operating Margin
19.6%
FY2025 EBITDA
$4,839 M
FY2025 Net Income (cont. ops)
$2,238 M
FY2025 Diluted EPS
$4.04
Q3 FY26 Revenue
$4,562 M
Q3 FY26 Gross Profit
$2,422 M
Q3 FY26 Gross Margin
53.1%
Q3 FY26 Operating Income
$901 M
Q3 FY26 Operating Margin
19.7%
Q3 FY26 Net Income
$618 M
Q3 FY26 Diluted EPS
$1.28
Q2 FY26 OCF
$779 M
Q2 FY26 FCF
$694 M
FY2025 OCF
$3,098 M
FY2025 CapEx
$431 M
FY2025 FCF
$2,667 M
FY2025 Dividends Paid
$1,192 M
FY2025 Buybacks
$1,167 M
FY2025 Debt Issued / (Repaid)
$5,241 M
TTM FCF
$3.71 B
TTM CapEx/Revenue
2.4%
TTM FCF/Revenue
19.9%
TTM Operating Margin
26.9%
TTM Net Margin
13.8%
TTM ROE
12.8%
TTM ROA
6.9%
FY2025 Cash & Equivalents
$1,544 M
Q2 FY26 Cash & Equivalents
$1,791 M
FY2025 Total Debt
$13,759 M
Q2 FY26 Total Debt
$14,057 M
FY2025 Net Debt
$11,572 M
Q2 FY26 Net Debt
$11,568 M
FY2025 Stockholders' Equity
$20,282 M
Q2 FY26 Stockholders' Equity
$20,303 M
FY2025 Goodwill & Intangibles
$27,651 M
Q2 FY26 Goodwill & Intangibles
$27,107 M
FY2025 Working Capital
($1,214) M
Q2 FY26 Working Capital
($1,403) M
Net Debt / EBITDA
2.0x
Interest Coverage
9.1x
Current Ratio
0.90
Dividend Annualized
$2.10/share
Consecutive Dividend Growth Years
67
YTD FY26 Buybacks
$610 M
Revenue CAGR (FY22-FY25)
9.3%
vs 200-Day MA
+11.7%
Strengths
Concerns
Emerson Electric has successfully transformed into a focused software-enabled industrial automation leader following the divestiture of Climate Technologies (Copeland/White-Rodgers) and Safety & Productivity (AspenTech/NI) segments. The company operates through Final Control and Intelligent Devices platforms serving process manufacturing, energy, chemicals, life sciences, and power end markets. Revenue grew at a 9.3% CAGR from FY22-FY25 to $18B, with gross margins expanding ~700 bps to 52.8% reflecting favorable mix shift toward software and automation. Operating margins reached 19.6% (GAAP) or 26.9% (TTM including acquisition amortization), demonstrating strong underlying earnings power. The company maintains a capital-light model with only 2.4% CapEx intensity and generates ~$3.7B in trailing FCF, fully funding ~$2.4B annual capital return (dividends plus buybacks). As a Dividend Aristocrat with 67 consecutive years of increases, EMR offers quality compound exposure to industrial automation secular growth trends, though the premium 34x P/E valuation and $11.6B net debt position require continued execution success.
Macro: Risk-on macro backdrop supporting industrial cyclicals: Polymarket prices 89% probability of zero Fed rate cuts in 2026 (up 3.3pp week-over-week), implying Fed on hold through year-end. Soft-landing consensus intact with only 8% US recession odds by end-2026. Japan recession risk at 20% (down 10pp WoW) and UK at 8% (down 4pp WoW). Global themes include Warsh inflation concerns weighing on gold, copper discussions around $7/lb supporting industrial metals demand, and uneven consumer backdrop per Walmart signals.